The NEXThaler is a new inhaler designed to more efficiently deliver medication to those who suffer from asthma.
The U.K. branch of the pharmaceutical company Chiesi and product developers Cambridge Consultants created the inhaler, which only delivers medicine when the recipient's breathing rate has reached an optimal level.
To use the NEXThaler, all you have to do is breathe in and wait for the inhaler to spray. Using a traditional inhaler isn't the toughest thing in the world to do, but timing it so that you spray at the right time can be tricky. The inhaler has already been rolled out in Germany and a wider rollout across Europe is expected to occur in the coming months.
Optimized Inhaler Redesigns
The NEXThaler is Designed to More Efficiently Deliver Medication
Trend Themes
1. Intelligent Inhalers - The development of smart inhalers that can detect and respond to individual respiratory patterns or environmental factors will transform the asthma market.
2. Connected Health - Inhaler devices which can transmit usage data wirelessly to healthcare providers and doctors offer a disruptive opportunity for enabling remote patient monitoring and intervention.
3. Medication Personalization - The introduction of inhalers that adjust the dose based on a patient's individual needs and the severity of their asthma offer a unique opportunity for personalized healthcare services.
Industry Implications
1. Pharmaceuticals - Pharmaceutical companies can leverage the development of optimized inhaler technology to secure market share and improve patient outcomes in the competitive respiratory drugs sector.
2. Health Technology - The growing adoption of digital health technologies, such as smart inhalers, offers a transformative opportunity for companies operating in the telehealth and mHealth sectors.
3. Medical Device - The redesigning of inhaler technology with a focus on patient convenience and efficacy presents a promising area for medical device manufacturers who have expertise in respiratory equipment design and development.